Literature DB >> 15203615

Vaginal misoprostol induction of labour: a Nigerian hospital experience.

O C Ezechi1, B K E Kalu, F O Njokanma, C A Nwokoro, G C E Okeke.   

Abstract

We reviewed our experience with vaginal misoprostol induction of labour in 339 consecutive women with a live fetus and intact fetal membrane using 100 mcg 12-hourly until labour was established. The labours were monitored using the WHO partograph protocol. Two hundred and sixty-five women had a successful induction while 74 had an emergency caesarean section because of cephalopelvic disproportion (63.5%), fetal distress (14.9%), prolonged labour (12.2%), antepartum haemorrhage (6.8%) and other indications (2.8%). The induction delivery interval among the women who had successful induction ranged from 3 hours 42 minutes to 26 hours 15 minutes with a mean of 9 hours 23 minutes (SD 2 hours 41 minutes). Most (73.6%) of these patients delivered within 12 hours of starting induction, the majority (95.3%) requiring only 100 mcg to go into established labour. Complications recorded in this series include fetal distress in 32 (9.4%), postpartum haemorrhage in 23 (6.8%), hyperstimulation in six (1.8%), uterine rupture in one (0.3%), birth asphyxia in eight (2.5%), admission in neonatal intensive care ward in five (1.5%), neonatal death in one (0.3%) and maternal death in one (0.3%) patient. In conclusion, misoprostol was found not only to be efficacious but relatively safe in comparison to other methods of induction in use in our hospital.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203615     DOI: 10.1080/01443610410001660698

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  1 in total

1.  Obstetric outcome and significance of labour induction in a health resource poor setting.

Authors:  Osaheni Lucky Lawani; Azubuike Kanario Onyebuchi; Chukwuemeka Anthony Iyoke; Chikezie Nwachukwu Okafo; Leonard Ogbonna Ajah
Journal:  Obstet Gynecol Int       Date:  2014-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.